Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 22, 2025
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting
GlobeNewswire
·
May 22, 2025
May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, …
Made in America: Inovair High-Efficiency Blowers Are the First to Meet BABA Requirements
GlobeNewswire
·
May 22, 2025
Lenexa, Kansas , May 22, 2025 (GLOBE NEWSWIRE) -- Building on over 30 years of innovation and manufacturing excellence, Inovair has been recognized by EPA as the first and only manufacturer of high-efficiency blower packages that are fully compliant with …
All Heart Homecare Wins Best of Brooklyn 2025 for Best Home Health Aides
GlobeNewswire
·
May 22, 2025
BROOKLYN, N.Y., May 22, 2025 (GLOBE NEWSWIRE) -- All Heart Homecare Agency is proud to announce that it has been named the winner of the Best of Brooklyn 2025 Award for Best Home Health Aides. This marks the agency’s fourth win overall and its third …
Quanex Building Products Announces Second Quarter 2025 Earnings Release and Conference Call Schedule
GlobeNewswire
·
May 22, 2025
HOUSTON, TEXAS, May 22, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its second quarter 2025 results on Thursday, June 5, 2025, after trading closes on the New York …
VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING
GlobeNewswire
·
May 22, 2025
Dallas, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 26, 2025 to stockholders of …
Stifel Reports April 2025 Operating Data
GlobeNewswire
·
May 22, 2025
ST. LOUIS, May 22, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for April 30, 2025 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature …
KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life
GlobeNewswire
·
May 22, 2025
GUADALAJARA, Mexico, May 22, 2025 (GLOBE NEWSWIRE) -- The countdown has begun, KMBIO an P2P exchange focusing on LATAM market has officially opened its private sale round as part of its fundraising campaign. In the midst of the global expansion of digital …
GENFIT Reports First Quarter 2025 Financial Information
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver …
GENFIT : Information financière du premier trimestre 2025
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du …
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
GlobeNewswire
·
May 22, 2025
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 …
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Rapid7 to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 22, 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 …
Cavco Industries Reports Fiscal 2025 Fourth Quarter and Year End Results
GlobeNewswire
·
May 22, 2025
PHOENIX, May 22, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) today announced financial results for the fourth quarter and fiscal year ended March 29, 2025. Quarterly Highlights Net revenue of $508 million up 21% from $420 million in the …
Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire
·
May 22, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …
Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 22, 2025
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …
Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
·
May 22, 2025
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …
Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
May 22, 2025
Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …